FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 1863796 · Received October 11, 2010

Report

Report Number
2124215-2010-16576
Event Type
Injury
Date Received
October 11, 2010
Date of Event
July 27, 2010
Report Date
July 30, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

TO DATE, THE LEAD AND DEVICE HAVE NOT BEEN RETURNED TO BOSTON SCIENTIFIC CRM. SHOULD THE PRODUCTS BE RETURNED; THE PRODUCTS WILL UNDERGO DETAILED LABORATORY ANALYSIS IN AN ATTEMPT TO CONFIRM AND DETERMINE THE ROOT CAUSE OF THIS EVENT.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THE PATIENT WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR EXPERIENCED AN INAPPROPRIATE SHOCK WHILE HOLDING AN INFANT. THE INFANT WAS SUBSEQUENTLY DROPPED AND EXPERIENCED A SKULL FRACTURE THAT REQUIRED SURGERY. THE INFANT HAS RECOVERED. UPON INTERROGATION OF THE DEVICE, IT WAS NOTED THAT THE INAPPROPRIATE SHOCK WAS LIKELY DUE TO OVERSENSING AS A RESULT OF A RIGHT VENTRICULAR DEFIBRILLATION LEAD FRACTURE WITH IMPEDANCES GREATER THAN 2000 OHMS. IT WAS ALSO NOTED THAT THE LEAD HAD INCREASED THRESHOLDS. A REVISION PROCEDURE WAS PERFORMED; THE LEAD AND DEVICE WERE REMOVED. THE PRODUCTS REMAIN WITH THE PATIENT AND WERE NOT RETURNED AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND F102

Patients

Seq Age Sex Outcome Treatment
1 Life Threatening| R